Delphia (USA) Inc. - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$76,284
-56.8%
10,212
-61.4%
0.12%
-44.4%
Q1 2023$176,555
+18.5%
26,470
+44.8%
0.22%
+109.7%
Q2 2022$149,00018,2810.10%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
CRV, LLC 733,986$16,889,00037.30%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 1,388,889$31,958,0005.87%
Yong Rong (HK) Asset Management Ltd 377,000$8,675,0005.69%
Samsara BioCapital, LLC 752,939$17,325,0002.72%
HARVARD MANAGEMENT CO INC 1,509,254$34,728,0002.04%
Spouting Rock Asset Management, LLC 52,851$1,216,0000.61%
PLATINUM INVESTMENT MANAGEMENT LTD 661,703$15,226,0000.43%
Laurion Capital Management LP 3,923,713$90,285,0000.38%
Casdin Capital, LLC 548,156$12,613,0000.31%
Baillie Gifford 22,061,374$507,632,0000.27%
View complete list of RECURSION PHARMACEUTICALS IN shareholders